Lucitanib
Lucitanib (E-3810) is a potent and selective small molecule inhibitor targeting vascular endothelial growth factor receptors (VEGFR1/2/3) and fibroblast growth factor receptors (FGFR1/2) . It has demonstrated anti-angiogenic and anti-tumor activity in preclinical studies, supporting its investigation in oncology research, particularly for cancers driven by these signaling pathways.
Product Specifications
CAS Number
1058137-23-7
Product Name Alternative
E3810, E-3810, E 3810, Lucitanib, inhibit, Inhibitor, FGFR, FGFR2, FGFR1, Fibroblast growth factor receptor, Vascular endothelial growth factor receptor, VEGFR3, VEGFR, VEGFR1, VEGFR2
Field of Research
Cardiovascular Research, Signal Transduction
Purity
95.68% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.51 mM) ; DMSO:25 mg/mL (56.37 mM)
Smiles
CNC (=O) c1cccc2cc (Oc3ccnc4cc (OCC5 (N) CC5) c (OC) cc34) ccc12
Molecular Formula
C26H25N3O4
Molecular Weight
443.49
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV692363 1.0 µg DNA
NPL Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details 
NBP2-79897AF405 0.1 mL
Mouse Monoclonal Ret Antibody (RET/2795) [Alexa Fluor 405]
Sign In for Pricing
View Details 
123861 100 µg
BCAP29 (B-Cell Receptor-Associated Protein 29, BCR-associated Protein 29, BAP29, DKFZp686M2086)
Sign In for Pricing
View Details KBH20498 96 Well
GENLISA™ Human C - Type Lectin Domain Family 4, Member A (CLEC4A) ELISA
Sign In for Pricing
View Details